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Background: Cancer has emerged as a major health problem globally as a consequence to the increased
longevity of the population, changing the environment and life style. Chemoprevention is a new and
promising strategy for reducing cancer burden. Recently, some natural products have been identiﬁed for
their chemopreventive activity to reduce the cancer incidence. Ginseng is known for its potential to treat
various ailments in human beings. The present study was designed to explore the anticancer and
antioxidative potential of Panax ginseng against chemical-induced skin carcinogenesis in mammals.
Methods: Skin tumors were induced in Swiss albino mice by a single topical application of 7,12-
dimethylbenz(a)anthracene (100 mg/100 mL acetone) and, 2 wks later, promoted by repeated applica-
tions of croton oil (thrice in a wk in 1% acetone) till the end of the experiment (i.e., 16 wk). Hydro-
alcoholic ginseng root extract at a dose of 25 mg/kg body weight/d was orally administered at the peri-
initiation, postinitiation, and periepost-initiation stages.
Results: Ginseng root extract treatment caused a signiﬁcant reduction in tumor incidence, cumulative
number of tumors, tumor yield, and tumor burden, as compared to the 7,12-dimethylbenz(a)anthracene
ecroton oil-treated control group. Further, biochemical assays revealed a signiﬁcant enhancement in the
levels of reduced glutathione, superoxide dismutase, catalase, vitamin C, and total proteins but a sig-
niﬁcant reduction in lipid peroxidation levels in both the liver and skin with ginseng root extract
treatment, as compared to carcinogen-treated control group.
Conclusion: These results suggest that P. ginseng has the potential to become a pivotal chemopreventive
agent that can reduce cancer in mammals.
Copyright  2015, The Korean Society of Ginseng, Published by Elsevier. All rights reserved.1. Introduction
Cancer has emerged as a serious global threat; it is the second
leading noncommunicable disease following cardiovascular disease
in the developed nations and the third fatal disease in developing
countries such as India. A great melioration in existing cancer
treatment methods is still ineffective to reduce the global burden of
this disease. The World Cancer Report (2014), developed by the
International Agency for Research on Cancer, predicts an acclivity of
new cancer cases from an annual estimation of 14million in 2012 to
22 million within 2 decades. Over the same period, cancer deaths
are expected to increase from 8.2 million to 13 million/yr. Exposure
to various chemicals, biological agents, and dietary habits as well as
life style contribute to cancer occurrence and in the probability ofgy Laboratory, Department of Zoo
al).
erms of the Creative Commons At
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ght  2015, The Korean Society ofdiagnosis [1]. However, 30e40% of cancer incidences can be pre-
vented by healthy dietary intervention and regular physical
activity.
The World Health Organization had launched a campaign
against cancer, with a three-fold strategy: prevent all the pre-
ventable cancers, cure all that can be cured, and reduce pain and
discomfort where cure is not possible [2]. The two most effective
ways to bring down the cancer risk are as follows: avoidance of
cancer-causing biological, chemical, and physical agents and an
increased intake of diet that has a chemopreventive action.
Skin carcinogenesis is growing rapidly in the developed coun-
tries due to the depletion of the ozone layer and changes in envi-
ronmental composition. Due to the high incidence of skin cancer in
Australia and European countries, it is regarded as a dreadedlogy, University of Rajasthan, Jaipur 302004, India.
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J Ginseng Res 2015;39:265e273266disease there [3]. The multistage skin carcinogenesis model is a
widely acceptable model to test tumor development at initiation
and promotion stages, and the preventive approach of drugs can be
easily evaluated [4].
Chemoprevention is the administration of natural or synthetic
compounds to prevent, slow down, and reverse the occurrence of
cancer. Various civilizations across the world still rely on herbal
medicines as the ﬁrst line of treatment. Owing to their safety, low
toxicity, antioxidant properties, cost effectiveness, and general
acceptance (as dietary supplements, fruits, vegetables, phyto-
chemicals, and minerals), these are being investigated for the
prevention of cancer. Extensive research over the past few decades
has identiﬁed numerous dietary and botanical natural compounds
that have anticancerous properties [5e7].
Panax ginseng belongs to the family Araliaceae and is commonly
grown in Korea. Ginseng is acclaimed as the magical herb that acts
as a restorative and prophylactic agent to treat various maladies
such as cancer. The active constituents of P. ginseng include ginse-
nosides, essential oil, peptidoglycans, polysaccharides, nitrogen-
containing compounds, fatty acids, and phenolic compounds.
Both below- and above-ground parts of this plant have medicinal
properties [8,9]. The root extract of ginseng has been empirically
used in Korea, Japan, and China for its role as an anticarcinogenic,
antidiabetic, antistress, antifatigue, anti-inﬂammatory, antioxidant,
and radioprotective agent [10e13].
Owing to the presence of a wide range of medicinal constituents
in P. ginseng, the present study was designed to evaluate the anti-
oxidative and antitumorigenic potential of this plant extract in a
mammalian model using a two-stage skin carcinogenesis protocol.
2. Materials and methods
2.1. Chemicals
The initiator 7,12-dimethylbenz(a)anthracene (DMBA) and the
promoter croton oil were procured from Sigma Chemicals Co. (St
Louis, MO, USA). DMBAwas dissolved at a concentration of 100 mg/
100 mL in acetone. Croton oil wasmixed in acetone to give a solution
of 1% dilution.
2.2. Animals
The protocol of the experiment was approved by the Institu-
tional Ethical Committee (1678/GO/a/12/CPCSEA), and animal care
and handling were done according to the guidelines set by the
World Health Organization, Geneva (Switzerland) and the Indian
National Science Academy, New Delhi (India). The present study
was conducted on Swiss albino mice (7e8-wk old and weighing
24  2 g) selected from a random breed inbreed colony. These
animals were housed in polypropylene cages in the animal house
under controlled conditions of temperature (25 2C) and light (14
light:10 dark). The animals were fed a standard mouse feed (pro-
cured fromAashirwad Industries, Chandigarh, India) andwater was
given ad libitum.Table 1
Phytochemical proﬁle in the korean red ginseng root extract
Sample no. Constituents
1. Total saponins
(ginsenosides)
Protopanaxadiol (20S) Ra1, Ra
Protopanaxatriol (20S) Re, Rf, R
Oleanolic acid Ro
2. Polysaccharide Panaxane AeU
3. Volatile oils A-cadinol, a-bisabolol, thujopsene, and
4. Rb1/Rg1 ratio 1e32.3. Phytochemical proﬁle of ginseng root
Korean Red Ginseng “Insam” was purchased from market. They
were 6-yr old fresh ginseng roots (main roots 70%þ ﬁne roots 30%)
with 14% moisture content. The ginsenoside (Rb1 þ Rg1) content
was 7.74 mg/g. Moreover, 30 types of ginsenosides and acidic
polysaccharides were present (Table 1).
2.4. Preparations of ginseng root extract
Red ginseng root powder was purchased, and its hydroalcoholic
extract was prepared by reﬂuxing it with double-distilledwater and
alcohol (3:1) in a roundbottomﬂask for 36hours (312hrs) at 60C.
The liquid extract was ﬁltered, cooled, and concentrated by evapo-
rating its liquid content using an oven, and collected. The powdered
extract, termed ginseng root extract (GRE), was dissolved again in
double-distilled water prior to its oral administration in mice.
2.5. Optimum dose selection
Different doses [5 mg/kg/body weight (b.wt)/d, 10 mg/kg/b.wt/
d, 25 mg/kg/b.wt/d, 50 mg/kg/b.wt/d, 100 mg/kg/b.wt/d, and
200 mg/kg/b.wt/d] of GRE were given orally for 15 consecutive
days, and themorphological and behavioral changes were recorded
for 30 d. The biochemical changes in the levels of lipid peroxidation
(LPO), glutathione (GSH), and total proteins in liver were estimated
after the 16th- and 30th-d autopsy. The dose showing the highest
levels of GSH and total proteins, and the lowest levels of LPO was
selected to carry out further experimentation.
The required dose for treatment was prepared by dissolving the
extract in double-distilled water at a dose of 25 mg/kg/b.wt.
2.6. Experimental design
Animals for this study were divided into the following groups:
Group I: vehicle-treated control group (normal) Mice (n ¼ 10)
belonging to this group received a topical application of acetone
(100 mL/mouse) on the shaven dorsal skin, and double-distilled
water (equivalent to GRE, i.e., 100 mL/mouse/d) by oral gavage
for 16 wks.
Group II: GRE-treated control group (negative control) Animals
(n ¼ 10) belonging to this group received GRE (25 mg/kg/b.wt/
animal/d) by oral gavage throughout the experimental period,
i.e., 16 wks, and acted as drug-treated controls.
Group III: carcinogen-treated control group (positive control)Mice
(n ¼ 10) belonging to this group were treated with a single
topical application of 100 mL DMBA (100 mg/100 mL acetone) over
the shaven area of the skin. Two wks later, 100 mL croton oil (1%
w/v in acetone) was applied topically three times per wk until
the end of the experiment.
Group IV: GRE-treated experimental group (peri-initiation) These
animals (n ¼ 10) received the same treatment of carcinogen as
Group III, and the GRE was orally administered at a dose ofExamples Reference
2, Ra3, Rb1, Rb2, Rb3, R4, Rs1, Rs2, Rs3, Rs4, Rc, Rd Fuzzati 2004 [45]
g1, R1
Kwak et al 2010 [46]
n-hexadecanoic acid Qui et al 2008 [47]
Chen et al 2008 [48]
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application to 7 d after the application.
Group V: GRE-treated experimental group (postinitiation) The
treatment pattern of DMBA and croton oil was the same as that
in Group III. This group (n ¼ 10) received GRE (25 mg/kg/b.wt/
animal/d) by oral gavage, starting from the time of croton oil
application until the end of the experiment.
Group VI: GRE-treated experimental group (peri- and post-
initiation) Animals (n¼ 10) of this groupwere administered GRE
(25 mg/kg/b.wt/animal/d) orally, starting at 7 d prior to DMBA
application and continuing throughout the experimental dura-
tion (i.e., 16 wks). The carcinogen treatment was the same as
that in Group III.2.7. Induction of tumor
For the induction of skin tumors, dorsal hairs between the cer-
vical and caudal portions of the animals of Groups IIIeVI wereTotal number of tumors in carcinogen treated control total number of tumors in GRE treated
Total number of tumors in carcinogen treated control  100removed using a surgical clipper, 2 d prior to the initiation of the
experiment, and 100 mL DMBA (100 mg/100 mL acetone) was
applied. After 14 d, the tumor initiation by DMBAwas promoted by
the topical application of 100 mL croton seed oil (1% v/v in acetone),
thrice per wk, for the next 14 wks.
During the 16 wks of experimentation, all mice were observed
daily and weighed weekly. Tumors appearing on the shaven area of
the skin were examined and recorded at weekly intervals in all the
above groups. Only those tumors that persisted for  2 wks, with a
diameter of > 2 mm, have been taken into consideration for the
ﬁnal evaluation of the data. Skin tumors, regressed after one
observation, were not accounted.
2.8. Morphological study
2.8.1. Cumulative number of tumors
The total number of tumors appeared till the termination of the
experiment were estimated.
2.8.2. Tumor incidence
The number of mice carrying at least one tumor was expressed
as a percentage incidence.
2.8.3. Tumor yield
The average number of tumors per mouse was calculated.
2.8.4. Tumor burden
The average number of tumors per tumor-bearing mouse was
estimated.
2.8.5. Diameter
The diameter of each tumor was measured.
2.8.6. Weight
The weight of each tumor was measured at the termination of
experiment.2.8.7. Body weight
The weight of each mouse was measured weekly.
2.8.8. Average latent period
The time lag between the application of the promoting agent
and the appearance of 50% of tumors was determined. The average
latent period was calculated by multiplying the number of tumors
appearing each wk by the time in wks after the application of the
promoting agent, and dividing the sum by the total number of
tumors.
Average latent period ¼
P
FX
N
where F is the number of tumors appearing each wk, X is the
numbers of wks, and N is the total number of tumors.
2.8.9. Inhibition of tumor multiplicity2.9. Biochemical study
The animals from all the groups were sacriﬁced by cervical
dislocation 16wks after the commencement of treatment, and their
liver and dorsal skin that were affected by tumors were quickly
excised and washed thoroughly with chilled 0.9% NaCl (pH 7.4).
Both of the tissues (liver and skin) were then weighed and blotted
dry. A 10% tissue homogenate was prepared from the part of the
tissue sample in 0.15M Tris-KCL (pH 7.4) to estimate the reduced
glutathione and LPO levels.
2.9.1. Reduced glutathione
The level of GSH was estimated as total nonprotein sulfhydryl
group by the method of Moron et al [14]. Free endogenous-SH was
assayed, and the absorbance was recorded at 412 nm using a UVe
VIS Systronics spectrophotometer. Reduced GSH was used as a
standard. The levels of GSH were expressed as mmol/g of tissue.
2.9.2. Lipid peroxidation
The LPO level was calculated spectrophotometrically by the
thiobarbituric acid reactive substances method, as described by
Ohkhawa et al [15]. The optical density of LPO was observed at
532 nm, and the content of thiobarbituric acid reactive substances
was expressed as nmol/mg of tissue.
2.9.3. Superoxide dismutase
Superoxide dismutase (SOD) level was determined according to
the method of Marklund and Marklund [16] by quantiﬁcation of
pyrogallol auto-oxidation inhibition, and the results were
expressed as units/mg protein. Auto-oxidation of pyrogallol in Tris-
HCL buffer (50mM, pH 7.5) was measured by the increase in
absorbance at 420 nm.
2.9.4. Catalase
Catalase activity was measured by the method of Aebi [17].
Phosphate buffer (50mM) was used for homogenate preparation
Table 2
Antitumorigenic potential of ginseng root extract on chemical-induced skin carci-
nogenesis in mice
Treatment
group1)
Body weight (g) No. of tumor Tumor
weight (g)
Initial Final
Normal 25.47  5.15 35.74  6.60 d d
Negative control 26.94  3.86 34.47  6.29 d d
Positive control 26.31  3.44 24.19  4.93 57.00  4.58 1.99  0.22
Peri-initiation 26.12  5.56 30.54  6.73* 39.67  4.73*** 1.2  0.19***
Postinitiation 25.87  4.20 31.78  3.54** 30.33  4.04*** 0.83  0.19***
Periepost-
initiation
27.45  4.11 32.89  5.28** 17.67  2.52*** 0.51  0.06***
Data are presented as mean  SD
Statistical comparison: control versus experimental
*p < 0.05
**p < 0.01
***p < 0.001
SD, standard deviation
1) Treatment schedule of the groups is speciﬁed in materials and methods
J Ginseng Res 2015;39:265e273268and centrifuged at 4307 g for 10min. The change in absorbancewas
observed spectrophotometrically at 240 nm. The activity of the
enzyme was expressed as U/mg of tissue, where U was mmol of
H2O2 disappearance/min.
2.9.5. Vitamin C
For this, the skin and liver tissue wereweighed, homogenized in
acetate buffer (20 mg/mL), extracted with cold 4% trichloroacetic
acid, centrifuged, and ﬁltered. Ascorbic acid was determined by the
method of Roe and Kuether [18].
2.9.6. Total proteins
Total protein content of the skin and liver was estimated by the
method of Lowry et al [19] by preparing homogenate in distilled
water, and absorbance was recorded at 670 nm. Protein concen-
tration was measured from a standard curve of bovine serum al-
bumin and the level was expressed as mg/g.
2.10. Histopathological study
On the completion of the 16th wk, the skin and tumor tissue
samples were collected for histopathological examination. Tissues
were treated in a series of alcohol grades, and blocks were prepared
by embedding in parafﬁnwax. Permanent slides were developed by
cutting 5-mm-thick sections, stained with hematoxylin and eosin,
and observed under a light microscope.
2.11. Statistical study
Data from different experimental groups were analyzed and
expressed as mean  standard deviation. The morphological dataFig. 1. Morphological variations in tumor appearance during chemical-induced skin carcin
extract.were evaluated using Student t test by Bourke et al [20]. The sig-
niﬁcant levels in biochemical parameters were statistically
computed using an analysis of variance (Stat Plus 2009, AnalystSoft
Inc company for Windows.), followed by Bonferroni test for dif-
ferences in means. A p value < 0.05 was considered signiﬁcant for
all experiments.
3. Results
3.1. Morphological study
As shown in Table 2, treatment with the GRE signiﬁcantly
affected the various stages of skin carcinogenesis in mice. The body
weight was found to be gradually increased during experimenta-
tion in Group I, but it was found to decrease in the carcinogen-
treated control animals.
Animals of Group III exhibited 100% tumor incidence after the
treatment with DMBA/croton oil alone, while the animals of Groups
I and II did not show any tumor appearance (Fig. 1).
The cumulative number of tumors in the carcinogen-treated
control group was noted as 57  4.58, which were signiﬁcantly
(p < 0.001) reduced to 39.67  4.73 in the peri-initiated group,
30.33 4.04 in the postinitiated group, and 17.67 2.52 in the perie
post-initiated group after GRE administration. The tumor yield
exhibited a signiﬁcant (p<0.001)decline, i.e., 3.970.47, 3.030.40,
and 1.77 0.25 in the GRE-treated Groups IVeVI, respectively, when
comparedwithGroup III. The tumorburdenwasnotedas5.70.46 in
the carcinogen-treated control group, and it was also signiﬁcantly
(p< 0.001) decreased to 4.99 0.71, 4.60 0.98, and 3.671.15 after
the administration of GRE in the experimental groups. Groups IVeVI
showed an appreciable elevation in the average latent period
(11.13  0.34, 12.02  0.14, and 12.86  0.28, respectively) in com-
parison to the control group (9.86  0.08; Table 3; Fig. 1).
3.2. Biochemical study
LPO level was found to be signiﬁcantly (p < 0.001) elevated in
the liver and skin of the animals in the carcinogen-treated control
group, when compared with the normal group. The administration
of the GRE in the experimental groups showed a signiﬁcant inhi-
bition of LPO in Group IV (p< 0.05), Group V (p< 0.001), and Group
VI (p < 0.001) in both the tissues (Tables 4 and 5).
The GSH level exhibited a signiﬁcant reduction in the positive
control group when compared with the normal group, and the
treatment with GRE signiﬁcantly restored the GSH activity in the
skin and liver of the animals in the peri-initiated (p < 0.01;
p < 0.05), postinitiated (p < 0.001, p < 0.01), and periepost-initi-
ated (p < 0.001; p < 0.001) groups (Tables 4 and 5).
In comparison with normal mice, the levels of antioxidant en-
zymes (SOD and catalase) in the liver and skin were observed toogenesis with or without GRE administration in different groups. GRE, ginseng root
Table 3
Chemopreventive potential of GRE on chemical-induced skin carcinogenesis in mice
Treatment group1) Tumor yield Tumor burden Average latent period Inhibition of tumor multiplicity (%) Tumor incidence (%)
Normal d d d d d
Negative control d d d d d
Positive control 5.7  0.46 5.7  0.46 9.86  0.08 d 100
Peri-initiation 3.97  0.47*** 4.99  0.71* 11.13  0.34*** 30.40 80
Postinitiation 3.03  0.40*** 4.60  0.99* 12.02  0.14*** 46.79 66.67
Periepost-initiation 1.77  0.25*** 3.67  1.15* 12.86  0.28*** 69 50
Data are presented as mean  SD
Statistical comparison: control versus experimental
*p < 0.05
**p < 0.01
***p < 0.001
GRE, ginseng root extract; SD, standard deviation
1) Treatment schedule of the groups is speciﬁed in materials and methods
Table 4
Variations in different biochemical parameters in liver during chemical-induced skin carcinogenesis with or without GRE administration
Treatment group LPO1) GSH2) SOD3) CAT4) Vit. C5) Total protein6)
Normal 2.57  1.09 7.99  0.67 69.02  5.57 46.38  6.22 2.48  0.38 111.21  15.38
Negative control 1.91  1.04 8.1  0.96 70.73  6.27 51.89  6.04 3.29  0.70 120.21  10.95
Positive control 9.39  2.40*** (265.37) 2.92  0.89*** (63.45) 37.87  8.46*** (45.13) 29.03  3.48*** (37.41) 1.37  0.35*** (44.76) 64.67  13.39*** (41.85)
Peri-initiation 6.63  2.36* (29.39) 4.41  1.06* (51.03) 50.07  7.53* (32.22) 35.64  4.08** (22.77) 2.00  0.27* (45.99) 86.92  15.57* (34.41)
Postinitiation 5.55  1.69*** (40.89) 4.6  1.02** (57.53) 53.82  10.28** (42.12) 38.91  5.96*** (34.03) 2.16  0.57** (57.66) 93.60  21.02** (44.73)
Periepost-
initiation
4.12  2.04*** (56.12) 5.79  1.31*** (98.29) 61.32  9.48*** (61.92) 42.09  5.04*** (44.99) 2.28  0.57*** (66.42) 107.08  12.95*** (65.58)
Data are presented as mean SD. Data in parentheses represent relative percentage change in parameters between normal versus positive control and positive control versus
experimental. Treatment schedule of the groups is speciﬁed in “Materials and methods” section. Statistical comparison: normal versus positive control and positive control
versus experimental
*p < 0.05
**p < 0.01
***p < 0.001
CAT, catalase; GRE, ginseng root extract; GSH, glutathione; LPO, lipid peroxidation; SD, standard deviation; SOD, superoxide dismutase; Vit., vitamin
1) nmol/mg tissue
2) mmol/mg tissue
3) Speciﬁc activity in mol/mg protein
4) mmol H2O2 consumed/min/mg protein
5) mg/mg tissue
6) mg/g tissue
Table 5
Variations in different biochemical parameters in skin during chemical-induced skin carcinogenesis with or without GRE administration
Treatment group LPO1) GSH2) SOD3) CAT4) Vit. C5) Total protein6)
Normal 2.97  0.80 5.09  1.22 61.07  12.01 43.72  6.29 2.40  0.65 98.48  14.79
Negative control 2.4  0.80 5.57  1.73 62.52  8.68 46.53  5.93 2.85  0.62 103.71  7.19
Positive control 10.5  1.66*** (253.54) 1.45  0.72*** (71.51) 27.6  5.63*** (54.81) 29.03  3.31*** (33.60) 1.18  0.45*** (50.83) 54.87  6.95***
(44.28)
Peri-initiation 8.68  1.14* (17.33) 2.77  0.91** (91.03) 36.54  4.92* (32.39) 35.64  3.38* (22.77) 1.79  0.81* (51.69) 70.16  9.54*
(27.87)
Postinitiation 7.73  1.52*** (26.38) 3.31  0.81*** (128.28) 46.71  9.29*** (69.24) 38.91  5.81*** (34.03) 2.18  0.46** (84.75) 72.73  12.77**
(32.55)
Periepost-
initiation
5.9  1.37*** (43.81) 4.15  0.70*** (186.21) 56.94  7.64*** (106.30) 42.09  6.73*** (44.98) 2.30  0.51*** (94.92) 107.08  13.58***
(95.15)
Data are presented as mean SD. Data in parentheses represent relative percentage change in parameters between normal versus positive control and positive control versus
experimental. Treatment schedule of the groups is speciﬁed in “Materials and methods” section. Statistical comparison: normal versus positive control and positive control
versus experimental
*p < 0.05
**p < 0.01
***p < 0.001
CAT, catalase; GRE, ginseng root extract; GSH, glutathione; LPO, lipid peroxidation; SD, standard deviation; SOD, superoxide dismutase; Vit., vitamin
1) nmol/mg tissue
2) mmol/mg tissue
3) Speciﬁc activity in mol/mg protein
4) mmol H2O2 consumed/min/mg protein
5) mg/mg tissue
6) mg/g tissue
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J Ginseng Res 2015;39:265e273270decrease signiﬁcantly (p  0.001) in the carcinogen-treated control
group. The SOD level was signiﬁcantly increased in the skin and
liver, after GRE administration in Group IV (p < 0.05; p < 0.05), V
(p < 0.001; p < 0.01), and Group VI (p < 0.001; p < 0.001),
respectively. The catalase content was recorded to be signiﬁcantly
(p < 0.001) higher in the vehicle-treated control group when
compared with the positive control group. Consumption of ginseng
extract in experimental Group IV (p < 0.05; p < 0.01), Group V
(p< 0.001; p< 0.001), and Group VI (p< 0.001; p< 0.001) restored
the catalase activity signiﬁcantly in both the skin and the liver
(Tables 4 and 5).
Further, the ascorbate activity was signiﬁcantly depleted in the
liver (p < 0.001) and skin (p < 0.001) after the application of a
carcinogen and a promoter in Group III, in comparison to the
normal group. The oral administration of GRE signiﬁcantly
increased the vitamin C content of the liver and skin in the animals
of Group IV (p < 0.05; p < 0.05), Group V (p < 0.01; p < 0.01), and
Group VI (p < 0.001; p < 0.001) when compared to Group III. The
total protein content was also found to be signiﬁcantly inhibited inFig. 2. Photographs (200) indicating histopathological variations in the skin tissue sections
V, and (E) Group VI. D, dermis, EH, epidermal hyperplasia; ER, erosion; HF, hair follicle; HKthe liver (p< 0.001) and skin (p< 0.001) of the animals of Group III
when compared to normal animals. The GRE intake by oral gavage
caused a signiﬁcant increment in the total protein content in the
liver and skin of the mice of Group IV (p < 0.05; p < 0.05), Group V
(p < 0.001; p < 0.01), and Group VI (p < 0.001; p < 0.001) in
comparison to carcinogen-treated animals (Tables 4 and 5).3.3. Histopathological study
The animals of the vehicle-treated control group exhibited a
uniform arrangement of skin layers, starting from the outer side
keratin layer, to the epidermis, dermis, and basal layer (Fig. 2A).
This symmetry was found to be disturbed in the carcinogen-treated
control animals in the form of hyperkeratosis, thickening of the
epidermis called epidermal hyperplasia, erosion of the epidermis,
and extension of the epidermis into the dermis (dermal invasion).
The sebaceous glands and hair follicles were also severely damaged
(Fig. 2B). The tumors of Group III mice exhibited large keratinizedof animals of different groups. (A) Normal group, (B) Group III, (C) Group IV, (D) Group
, hyperkeratosis; SG, sebaceous gland.
Fig. 3. Photographs (200) indicating the histological sections of tumors in animals of different groups. (A) Group III, (B) Group IV, (C) Group V, and (D) Group VI. AC, acanthosis;
AN, atypical nuclei; DY, dyskeratosis; KP, keratinocyte pearl; RD, reduced stroma; TN, tumor nest.
J. Sharma and P.K. Goyal / Chemoprevention by ﬂaxseed oil 271pearls, acanthosis, reduced stroma, and high inﬁltration of lym-
phocytes (Fig. 3A).
After the administration of GRE in Groups IVeVI, the severity of
damage to the skin was less. The skin showed reduced hyperker-
atosis and epidermal hyperplasia in peri-initiation and post-
initiation groups, which were further decreased in Group VI
animals (Fig. 2CeE).
The number and size of keratinized pearls, acanthosis, and tu-
mor nests were also noted to be reduced after the GRE treatment in
different groups (Fig. 3BeD). Peri- and postinitiation treatment
groups (treated with ginseng extract) exhibited a minor distur-
bance in the skin architecture and small-sized keratinized pearls
(Fig. 2E, 3D).
4. Discussion
The continuous rise in cancer incidence has become a challenge
for clinicians and scientists. Existing techniques such as chemo-
therapy and radiotherapy are generally used for cancer treatment,
but they are also associated with various limitations and side ef-
fects. Therefore, the search for new preventive therapies to reduce
the global cancer burden is gaining momentum. Natural dietary
supplements have been evidenced to possess many chemo-
preventive properties due to the presence of antioxidative and anti-
inﬂammatory substances [21].
Roots of P. ginseng have bioactive compounds, including a series
of triterpenoids and saponins, with steroidal structures similar tothose of ginsenosides (Rg3, Rb1, Rc, Re, and Rg1) [22]. Scientiﬁc
evidence suggests that the presence of Rg3 is associated with the
anticarcinogenic potential of GRE [23]. The expression of ornithine
decarboxylase, a biochemical marker for tumor promotion, and
cyclooxygenase-2, a crucial factor for generating an inﬂammatory
effect, were signiﬁcantly reduced by Rg3 alone [24,25].
The mouse chemical-induced multistage skin carcinogenesis
model is a particularly useful model to examine the genetic and
biochemical changes. In the present experiment, the topical
application of DMBA was used to initiate carcinogenesis because
skin absorption was reported to be the fastest route of entry for
these polycyclic aminohydrocarbons. The metabolic activation of
DMBA takes place in the liver by Phase-I detoxiﬁcation enzyme
cytochrome P450, which converts it into 3, 4-diol-1, 2-epoxide that
covalently binds to DNA and form DNA adducts, ultimately leading
to mutation. Croton oil contains 12-O-tetradecanoylphorbol-13-
acetate, which is used for skin tumor promotion by the produc-
tion of reactive oxygen species and hydroperoxides in keratinocytes
[26].
In the current study, the animals treated with DMBA/croton oil
alone showed 100% tumor incidence, and high tumor yield, tumor
burden, and short average latent period due to their carcinogenic
potential in the absence of any treatment. After the administration
of GRE, a signiﬁcant reduction occurred in the cumulative number
of tumors, and the average latent period was also prolonged.
The consumption of crude plant extracts also showed a signiﬁ-
cant improvement in all biochemical parameters by restoring them
J Ginseng Res 2015;39:265e273272to normal levels. Free radicals generated by the carcinogen lead to
the deterioration of membranes and proteins by the LPO reaction.
Various aldehydes, e.g., acrolein, malondialdehyde, and 4-hydroxy-
2-nonenal, are formed as secondary metabolites during the per-
oxidation reaction [27,28]. In the present study, the level of
increased malondialdehyde in Group III was associated with the
adverse effect of carcinogen, which was found to be reduced during
the GRE treatment. Administration of ginseng extract at the perie
post-initiation stage was found to be most effective in reducing
malondialdehyde formation during carcinogenesis.
The carcinogen-treated control group was deprived of antioxi-
dants such as GSH, SOD, and catalase because these are consumed
during the oxidative stress, but the GRE administration, in the
present experiment, normalized the antioxidant content of the
cells. Reduced GSH, a tripeptide of amino acids L-glutamate, L-
cysteine, and L-glycine, is the most abundant cytosolic thiol and the
principal antioxidant used to scavenge free radicals, as well as an
essential cofactor to GSH peroxidases and GSH S-transferases for
detoxifying nonradical oxidants [29]. Depletion in the GSH levels
was reduced in Groups IVeVI after GRE treatment. When ginseng
was given throughout the experimental period, it showed best
results in comparison to the peri-and postinitiation groups.
SOD is a metalloprotein and chain-breaking antioxidant that
converts superoxide radicals into hydrogen peroxide, precluding
the generation of reactive oxygen species cascade, including
hydrogen peroxide (H2O2), hypochlorite (OCl), peroxynitrate
(ONO2), and hydroxyl radical (HO). Further, catalase breaks down
H2O2 into water and oxygen [30,31]. The augmentation in the SOD
and catalase level during the current study demonstrates the
antioxidative potential of GRE. The additional dose of antioxidant in
the form of GRE helped to restore the levels in the present exper-
iment. Treatment prior to the DMBA application might prevent
cancer, but it was more effective when continued till the end of the
experiment. Similarly, vitamin C also decimates free radicals in a
carcinogenic condition; its level was reduced in Group III, but after
the treatment with GRE, it meliorated [32]. The best results were
obtained in Group VI due to a continuous supply of GRE as an
antioxidant to suppress the adverse effect of carcinogenesis. The
outcomes were less effective in Group IV and Group V.
Severe destruction of the skin histology was observed in Group
III after the carcinogen treatment alone, and the same results were
also noted in previous studies [33,34]. Epidermal hyperplasia and
dermal invasion due to hyperproliferation were signs of Squamous
Cell Carcinoma (SCC) development. The formation of horny pearls,
tumor nests, and acanthosis represented the carcinogenic effect of
DMBA/croton oil, which was found to be decreased after the
administration of ginseng extract at different stages.
It has been evident that the acidic polysaccharides of P. ginseng
have a radioprotective effect on bonemarrow cells in vitro [35]. GRE
was also reported to inhibit chromosomal aberrations, intestinal
damage, hematological alterations, and depletion of germ cells in
the testes during radiation-induced injuries in vivo [36e39]. It has
been manifested that ginsenosides are the most effective constit-
uents of ginseng for the treatment and prevention of cancer. These
ginsenosides are triterpenoid glycosides; a total of 34 kinds of
ginsenosides have been isolated fromwhite, red, and fresh ginseng
till now. Besides, nonsaponin constituents, e.g., polyacetylenes,
sesquiterpenes, alkaloids, aminoglycosides, oligopeptides, etc. [40],
of ginseng roots are also attracting attention due to their anti-
oxidative, anticancer, antidiabetic, immunomodulatory, and anti-
complementary properties [41]. Types of ginsenosides vary among
different parts of a plant, so every part has important medicinal
values.
Anticancer properties of ginseng were also previously evaluated
for chemical-induced carcinogenesis models, such as benzo[a]pyrene-induced lung adenoma in mice, diethylnitrosamine-
induced liver cancer in rats, and azoxymethane-induced colo-
rectal cancer in SpragueeDawley rats [42e44].
The results obtained from the present study suggest that GRE
has the potential to reduce oxidative stress and tumorigenesis, by
restoring the antioxidative enzymes, in mammals.Conﬂicts of interest
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